China’s Premier Li Qiang is stepping up efforts to create a fairer business environment and boost innovation in the pharmaceutical industry. In a recent government meeting, he pushed for stricter regulations on how businesses are inspected, aiming to cut down on unnecessary and arbitrary checks that disrupt operations.
Local authorities have sometimes taken actions that negatively affect businesses, causing uncertainty and making it harder for companies to thrive. Premier Li emphasized the need to stabilize the market and ensure that inspections are conducted fairly and according to clear standards.
The meeting also focused on improving the way medicines and medical devices are regulated in China. The goal is to strengthen the country’s pharmaceutical industry and meet people’s growing demand for high-quality healthcare products.
To achieve this, the government plans to support research and innovation, speed up approval processes for new medicines, and enhance oversight to ensure safety and effectiveness. They are also encouraging the industry to open up and collaborate more on a global scale.
Additionally, leaders discussed ways to improve food safety and promote high-quality development across different regions. Areas that contribute more taxes and show faster income growth might receive extra support to continue their progress.
In the financial sector, new rules were approved to standardize services offered by intermediaries in public stock offerings, aiming to make the market more transparent and efficient.
These moves reflect China’s commitment to fostering a better environment for businesses and innovation, which could have a significant impact both domestically and internationally.
Reference(s):
Premier Li urges strict regulation of enterprise inspections
cgtn.com
